The Seventh Prevention of Syncope Trial (POST VII)-A randomized clinical trial of atomoxetine for the prevention of vasovagal syncope: Rationale and study design.

Sandhu, Roopinder K; Raj, Satish R; Hamzeh, Rasha; Sheldon, Robert S

Sandhu, Roopinder K; Raj, Satish R; Hamzeh, Rasha; Sheldon, Robert S.

Afiliação

Sandhu RK; Smidt Heart Institute, Cedars-Sinai Hospital, Los Angeles, CA; Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada. Electronic address: roopinder.sandhu@cshs.org.
Raj SR; Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Hamzeh R; Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Sheldon RS; Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Am Heart J ; 262: 49-54, 2023 08.

Article em En | MEDLINE | ID: mdl-37100187

Assuntos

Síncope Vasovagal; Humanos; Síncope Vasovagal/tratamento farmacológico; Cloridrato de Atomoxetina/uso terapêutico; Qualidade de Vida; Estudos Cross-Over; Recidiva; Método Duplo-Cego

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síncope Vasovagal Tipo de estudo: Clinical_trials / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google